[Hub]/) : Traits : Medication: Bendroflumethiazide :

chr11:1,213,806-2,640,824

Best TWAS P=3.45e-15 · Best GWAS P=3.61e-16 conditioned to 0.0566

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 GTEx Cells Transformed fibroblasts LSP1 0.21 0.04 enet 28 0.06 3.4e-05 7.8 6.2 5.0e-10 0.68 0.02 0.98 FALSE
2 GTEx Skin Not Sun Exposed Suprapubic TNNT3 0.33 0.16 lasso 7 0.17 2.0e-09 6.5 7.0 1.9e-12 0.87 0.03 0.97 TRUE
3 YFS Blood TNNT3 0.02 0.02 lasso 3 0.01 1.9e-05 6.5 -5.7 8.9e-09 -0.79 0.05 0.94 FALSE
4 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma LSP1 0.12 0.08 lasso 5 0.10 5.0e-11 -7.7 -7.9 3.5e-15 -0.61 0.03 0.97 TRUE
5 The Cancer Genome Atlas Brain Lower Grade Glioma LSP1 0.06 0.04 enet 6 0.04 3.1e-05 5.8 5.4 6.3e-08 0.12 0.63 0.07 FALSE
6 The Cancer Genome Atlas Lung Squamous Cell Carcinoma LSP1 0.07 0.03 lasso 4 0.03 2.4e-04 5.9 -7.4 1.1e-13 -0.35 0.08 0.35 FALSE
7 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma TNNI2 0.11 0.09 lasso 2 0.08 4.1e-06 5.9 -5.9 4.7e-09 -0.17 0.59 0.08 TRUE